Pages that link to "Q28731034"
Jump to navigation
Jump to search
The following pages link to Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease (Q28731034):
Displaying 47 items.
- HIV and aging: emerging research issues (Q27016011) (← links)
- 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention: summary of key research and implications for policy and practice - clinical sciences (Q30494770) (← links)
- Enhanced effector function of CD8(+) T cells from healthy controls and HIV-infected patients occurs through thrombin activation of protease-activated receptor 1. (Q30532710) (← links)
- Systemic effects of inflammation on health during chronic HIV infection (Q33577551) (← links)
- Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection (Q34315572) (← links)
- Association of markers of hemostasis with death in HIV-infected women (Q34342193) (← links)
- Immune activation and HIV persistence: implications for curative approaches to HIV infection (Q34351320) (← links)
- The innate immune response in HIV/AIDS septic shock patients: a comparative study (Q34850755) (← links)
- Effects of atorvastatin and pravastatin on immune activation and T-cell function in antiretroviral therapy-suppressed HIV-1-infected patients (Q35115728) (← links)
- Factors associated with D-dimer levels in HIV-infected individuals (Q35120065) (← links)
- Persistently Elevated C-Reactive Protein Level in the First Year of Antiretroviral Therapy, Despite Virologic Suppression, Is Associated With HIV Disease Progression in Resource-Constrained Settings (Q36654575) (← links)
- Persistently elevated serum interleukin-6 predicts mortality among adults receiving combination antiretroviral therapy in Botswana: results from a clinical trial (Q36937881) (← links)
- Effect of statin therapy in reducing the risk of serious non-AIDS-defining events and nonaccidental death (Q36956948) (← links)
- Baseline Inflammatory Biomarkers Identify Subgroups of HIV-Infected African Children With Differing Responses to Antiretroviral Therapy (Q37033083) (← links)
- Combination antiretroviral therapy with raltegravir leads to rapid immunologic reconstitution in treatment-naive patients with chronic HIV infection. (Q37247467) (← links)
- Accelerated biological ageing in HIV-infected individuals in South Africa: a case-control study (Q37247822) (← links)
- Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression (Q37445168) (← links)
- Inflammatory co-morbidities in HIV+ individuals: learning lessons from healthy ageing (Q38177684) (← links)
- Role of inflammation in HIV-1 disease progression and prognosis (Q38183454) (← links)
- Potential implication of residual viremia in patients on effective antiretroviral therapy (Q38271917) (← links)
- Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation (Q38858603) (← links)
- Inflammatory Biomarkers and Mortality Risk Among HIV-Suppressed Men: A Multisite Prospective Cohort Study (Q40637001) (← links)
- Interleukin 6 Is a Stronger Predictor of Clinical Events Than High-Sensitivity C-Reactive Protein or D-Dimer During HIV Infection (Q40692524) (← links)
- Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy (Q40954848) (← links)
- Intestinal Damage and Inflammatory Biomarkers in Human Immunodeficiency Virus (HIV)-Exposed and HIV-Infected Zimbabwean Infants (Q41932805) (← links)
- Inflammation Related Morbidity and Mortality Among HIV-Positive Adults: How Extensive Is It? (Q41989633) (← links)
- Potential anti-inflammatory effects of maraviroc in HIV-positive patients: a pilot study of inflammation, endothelial dysfunction, and coagulation markers. (Q42219111) (← links)
- Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patients (Q42318292) (← links)
- Human Immunodeficiency Virus 1 and Type I Interferons-Where Sex Makes a Difference (Q42369099) (← links)
- A comparison of the association between glomerular filtration and L-arginine status in HIV-infected and uninfected African men: the SAfrEIC study. (Q46333565) (← links)
- Systemic Inflammation, Coagulation, and Clinical Risk in the START Trial (Q47095325) (← links)
- Impact of aging and HIV infection on serologic response to seasonal influenza vaccination (Q50101280) (← links)
- Management of Long-Term Complications of HIV Disease: Focus on Cardiovascular Disease. (Q52566637) (← links)
- Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial (Q56912547) (← links)
- Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial (Q56912555) (← links)
- Virological and immunological responses to raltegravir and dolutegravir in the gut-associated lymphoid tissue of HIV-infected men and women (Q57101005) (← links)
- Inflammation and micronutrient biomarkers predict clinical HIV treatment failure and incident active TB in HIV-infected adults: a case-control study (Q58701586) (← links)
- Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection (Q60045562) (← links)
- Effect of baseline micronutrient and inflammation status on CD4 recovery post-cART initiation in the multinational PEARLS trial (Q62489966) (← links)
- Increased mucosal neutrophil survival is associated with altered microbiota in HIV infection (Q64057021) (← links)
- Sex Differences in Neurocognitive Function in Adults with HIV: Patterns, Predictors, and Mechanisms (Q90111815) (← links)
- E-Selectin and markers of HIV disease severity, inflammation and coagulation in HIV-infected treatment-naïve individuals (Q91601845) (← links)
- Inflammatory biomarkers prior to antiretroviral therapy as prognostic markers of 12-month mortality in South Africa and Uganda (Q91632960) (← links)
- C - reactive protein and interleukin - 6 levels among human immunodeficiency virus -infected patients with dysglycemia in Tanzania (Q92086036) (← links)
- Inflammatory biomarker levels over 48 weeks with dual vs triple lopinavir/ritonavir-based therapy: Substudy of a randomized trial (Q93147271) (← links)
- A therapeutic HIV-1 vaccine reduces markers of systemic immune activation and latent infection in patients under highly active antiretroviral therapy (Q94587776) (← links)
- Changes in D-dimer after initiation of antiretroviral therapy in adults living with HIV in Kenya (Q97567577) (← links)